Target intelligence / Profile preview

ANAPC1 pseudogene 5 (ANAPC1P5)

Target
ANAPC1P5
Molecular classification
Other (specifically, pseudogene)
01

Overview

ANAPC1P5 (ANAPC1 pseudogene 5) is a pseudogene of the human genome (NCBI Gene ID: 100420890, Ensembl: ENSG00000275597). It has no protein-coding function and does not produce any functional RNA or protein product. ANAPC1P5 is most likely named for its sequence homology to the ANAPC1 gene, which encodes a real subunit of the anaphase-promoting complex, a cell cycle-regulating E3 ubiquitin ligase[4][5]. There are no known biological functions, disease associations, or drug interactions for this pseudogene. Pseudogenes like ANAPC1P5 are not considered therapeutic targets, receptors, enzymes, or druggable entities in biomedical research. The inclusion of ANAPC1P5 as a "target" is incorrect, as it is neither a receptor nor a protein-coding gene, and thus should not be considered a legitimate target in pharmacology or molecular biology[4][5]. Additional context: - Pseudogenes are sometimes transcribed, but generally do not encode functional products and are not involved directly in biological pathways or known disease mechanisms. - No molecular classifications (e.g., receptor, enzyme, transporter, transcription factor) apply to ANAPC1P5, aside from "Other" as a pseudogene. - No drugs, mechanisms of action, biomarkers, or safety concerns are associated with ANAPC1P5. If you intended the functional, protein-coding ANAPC1 gene, refer to "anaphase promoting complex subunit 1"[1][2][3], which is a vital regulator of the cell cycle and is associated with cell proliferation, cancer, and other biological functions, but ANAPC1P5 is distinctly a non-functional pseudogene[4][5].

Other names
ANAPC1 pseudogene 5ANAPC1P5

Beyond the preview

Go deeper on ANAPC1 pseudogene 5 (ANAPC1P5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ANAPC1 pseudogene 5 (ANAPC1P5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call